1.
Clin Transl Oncol
; 20(1): 84-88, 2018 Jan.
Artículo
en Inglés
| MEDLINE
| ID: mdl-29098554
RESUMEN
Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiation therapy is an essential component of curative-intent of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.